Figure 4

LC3/β-actin (a), p-ERK/ERK (b), Beclin 1/β-actin (c) concentrations and gel electrophoresis of the tested genes (d) against the potent trials in Caco-2 cell line.

LC3/β-actin (a), p-ERK/ERK (b), Beclin 1/β-actin (c) concentrations and gel electrophoresis of the tested genes (d) against the potent trials in Caco-2 cell line.